From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.51 CNY | +10.03% | +2.04% | -14.14% |
1st Jan change | Capi. | |
---|---|---|
-14.14% | 292M | |
+13.97% | 8.2B | |
+5.29% | 7.61B | |
+0.60% | 5.95B | |
-6.04% | 3.72B | |
-10.75% | 3.57B | |
-7.53% | 1.27B | |
-29.55% | 1.07B | |
+14.57% | 988M | |
-12.85% | 890M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.